Cerapedics earned FDA approval to expand the use of its spinal fusion biologic, i-Factor P-15, according to a Sept. 24 news release.

Here are five companies making spine and orthopedic biologic products:

Bone marrow aspirate injections didn't lead to significant changes for patients who had  arthroscopic partial meniscectomy, according to a Sept. 15 study in The American Journal of Sports Medicine.

Spine biologics is a realm ripe for exploration of its potential and applications in patient care.

Regenerative medicine in spine surgery is on the rise, and there are many biologic tools that physicians say could be used more in the field.

Temple Therapeutics, a women's health company, launched a spinoff venture for orthopedic sports medicine, according to a Sept. 9 news release.  

Growing biologics portfolios will play a key role in pushing the spine surgery device market in the coming years, according to a report from Coherent Market Insights.

From product debuts and approvals, here are four key updates from orthobiologic companies since June 4.

LifeNet Health, in partnership with Johnson & Johnson MedTech, launched the PliaFX Pak bone allograft in the U.S., according to an Aug. 27 news release shared with Becker's.

Elutia, formerly Aziyo Biologics, has continued to face litigation related to spine biologics allegedly linked to tuberculosis infections that were recalled in recent years.

One of 10 former MiMedx employees involved in a noncompete lawsuit has filed counterclaims against the company. 

Vericel earned FDA approval for a supplemental Biologics License Application, which will expand the company's Maci label to include arthroscopy, according to an Aug. 26 news release.

SurGenTec earned FDA 510(k) clearance for its B-Man bone marrow aspirate kit, according to an Aug. 23 news release.

Ossium Health's OssiGraft Prime was used in its first successful case, the orthobiologic company said July 30.

Phoenix-based Full Circle Orthopedics and Sports Medicine added mVasc treatment for orthopedic healing, according to a July 24 news release.

Regenerative medicine in spine and orthopedic surgery is growing, but its exact place in the specialties hasn't been fully cemented yet.

Tallahassee (Fla.) Orthopedic Clinic has opened a new orthotics and prosthetics suite.

From product debuts to new research, here are five key developments in orthobiologics since May 6.

OssDsign's Catalyst nanosynthetic bone graft was used in its 5,000th U.S. patient, the medtech company said May 30.

New York City orthopedic surgeon Steven Struhl, MD, has completed his first procedure using Cartiheal's Agili-C implant for regenerating articular cartilage.